Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase.

Concise syntheses of orlistat (Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.

[1]  J. Yadav,et al.  Stereoselective synthesis of (-)-tetrahydrolipstatin via a radical cyclization based strategy , 2006 .

[2]  Jeffrey W. Smith,et al.  Practical, catalytic, asymmetric synthesis of beta-lactones via a sequential ketene dimerization/hydrogenation process: inhibitors of the thioesterase domain of fatty acid synthase. , 2006, The Journal of organic chemistry.

[3]  Jian Yin,et al.  Total Synthesis of (-)-Tetrahydrolipstatin by the Tandem Mukaiyama-aldol Lactonization , 2005 .

[4]  B. Chakravarty,et al.  Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jeffrey W. Smith,et al.  A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2* , 2004, Journal of Biological Chemistry.

[6]  Jeffrey W. Smith,et al.  Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.

[7]  R. Batey,et al.  Diastereoselective allylations and crotylations under phase-transfer conditions using trifluoroborate salts: an application to the total synthesis of (−)-tetrahydrolipstatin , 2003 .

[8]  R. Grubbs,et al.  A general model for selectivity in olefin cross metathesis. , 2003, Journal of the American Chemical Society.

[9]  M. McLeod,et al.  The total synthesis of (−)-tetrahydrolipstatin , 2003 .

[10]  D. Romo,et al.  Concise total synthesis of (+)-brefeldin A: a combined beta-lactone/cross-metathesis-based strategy. , 2002, Organic letters.

[11]  Arun K. Ghosh,et al.  A stereoselective synthesis of (-)-tetrahydrolipstatin. , 1999, Chemical communications.

[12]  D. Romo,et al.  A Stereocomplementary Approach to β-Lactones: Highly Diastereoselective Synthesis of cis-β-Lactones, a β-Chloro Acid, and a Tetrahydrofuran , 1999 .

[13]  C. Kouklovsky,et al.  Oxazoline N-oxide-mediated [2+3] cycloadditions. Application to a synthesis of (-)-tetrahydrolipstatin. , 1999, Organic letters.

[14]  I. Paterson,et al.  anti-Aldol reactions of lactate-derived ketones. Application to the synthesis of (−)-tetrahydrolipstatin , 1999 .

[15]  D. Romo,et al.  A β-Lactone-Based Strategy Applied to the Total Synthesis of (8S,21S,22S,23R)- and (8R,21S,22S,23R)-Okinonellin B , 1998 .

[16]  Haifeng Yang,et al.  Studies of the tandem Mukaiyama aldol-lactonization (TMAL) reaction: A concise and highly diastereoselective route to β-lactones applied to the total synthesis of the potent pancreatic lipase inhibitor, (−)-Panclicin D , 1997 .

[17]  D. Romo,et al.  A Highly Diastereoselective, Tandem Mukaiyama Aldol-Lactonization Route to beta-Lactones: Application to a Concise Synthesis of the Potent Pancreatic Lipase Inhibitor, (-)-Panclicin D. , 1997, The Journal of organic chemistry.

[18]  Michael G. Yang,et al.  A Stereochemical Model for Merged 1,2- and 1,3-Asymmetric Induction in Diastereoselective Mukaiyama Aldol Addition Reactions and Related Processes , 1996 .

[19]  S. Hanessian,et al.  Total Synthesis of (-)-Tetrahydrolipstatin , 1993 .

[20]  S. Ley,et al.  The use of π-allyltricarbonyliron lactone complexes in the synthesis of the β-lactone esterase inhibitor (−)-valilactone. , 1991 .

[21]  P. Wovkulich,et al.  Synthesis of Tetrahydrolipstatin. , 1991 .

[22]  S. Ley,et al.  Synthesis of the β-lactone esterase inhibitor valilactone using π-allyltricarbonyliron lactone complexes. , 1991 .

[23]  P. Kocieňski,et al.  Synthesis of (–)-Tetrahydrolipstatin , 1989, Synfacts.

[24]  P. Hadváry,et al.  Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. , 1988, The Biochemical journal.

[25]  B. Borgström.  Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. , 1988, Biochimica et biophysica acta.

[26]  P. Barbier,et al.  Synthesis of tetrahydrolipstatin and tetrahydroesterastin, compounds with a .beta.-lactone moiety. Stereoselective hydrogenation of a .beta.-keto .delta.-lactone and conversion of the .delta.-lactone into a .beta.-lactone , 1988 .

[27]  P. Barbier,et al.  Stereoselective Syntheses of Tetrahydrolipstatin and of an Analogue, Potent Pancreatic‐Lipase Inhibitors Containing a β‐Lactone Moiety , 1987 .

[28]  A. K. Ghosh,et al.  Asymmetric synthesis of (-)-tetrahydrolipstatin: an anti-aldol-based strategy. , 2000, Organic letters.

[29]  B. Giese,et al.  Diastereoselective Radical Addition as a Key-Step in the Synthesis of Tetrahydrolipstatin , 1996 .

[30]  Loretta L. Wong,et al.  An Asymmetric Synthesis of (-)-Tetrahydrolipstatin , 1994 .

[31]  I. Fleming,et al.  A synthesis of (−)-tetrahydrolipstatin in which the relative stereochemistry is controlled by a phenyldimethylsilyl group , 1990 .